26 results
8-K/A
EX-99.2
NTBL
Notable Labs Ltd
29 Nov 23
Financial Statements and Exhibits
5:00pm
of (a) the closing of the sale of shares of Common Stock to the public in a firm-commitment underwritten public offering pursuant to an effective
8-K
EX-99.1
NTBL
Notable Labs Ltd
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
-track additional undervalued assets as it builds out its development pipeline.
“I want to thank the entire Notable team for their commitment to our
425
EX-10.1
NTBL
Notable Labs Ltd
2 Oct 23
Business combination disclosure
5:31pm
” shall mean any indebtedness, obligation, commitment, expense, claim, loss, damage, deficiency, costs, duty, guaranty or obligation of or by any Person … or pledge agreement, commitment, license, lease, franchise, permit, agreement, authorization, concession, or other instrument or obligation to which
8-K
EX-10.1
q7uyjk3vgjpqcv
2 Oct 23
Other Events
5:30pm
424B3
829cwmqzal f6
2 Oct 23
Prospectus supplement
5:29pm
424B3
k3a0qjniwz0fx43i1g
5 Sep 23
Prospectus supplement
6:02pm
S-4/A
5mjufpclg6d
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4/A
EX-10.20
jzi3u95p
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
qgym2
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-2.2
mujw8rryr
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-2.3
m00o2zrqczx5r
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.11
xu7ftgb9goemq1d6
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-99.3
0q6tj9b
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
424B5
f0m0kie37ussrgfx
12 May 20
Prospectus supplement for primary offering
12:02pm